Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Jobswatch

Software company to create 50 jobs with expansion to Dublin

ArisGlobal, which makes software for the pharmaceutical and medical devices industries, is to set up in Ireland.

A COMPANY developing software for the pharmaceutical, medical and life sciences industries is to create 50 jobs by expanding its European operations to create a Dublin office.

ArisGlobal provides software products to regulatory affairs, clinical research and medical information enterprises.

The company already has operations worldwide in locations including the USA, Britain, India and Japan, with a total global workforce of over 700.

The jobs are being created with the support of IDA Ireland.

Jobs minister Richard Bruton said the expansion was “a clear message that Ireland offers a strong business environment in which companies can expand and grow their global presence which will result in the creation of valuable job opportunities for this economy”.

ArisGlobal chief executive Deepak Abbhi said the decision to locate in Ireland meant it could “take the lead in providing cloud based solutions for pharmaceutical research and development”.

“In addition this expansion will strengthen sales and marketing and services delivery for the company’s European market as part of our global expansion,” he said.

Abbhi added that the firm had chosen Ireland for expansion “due to the availability of a highly-skilled and flexible workforce and a competitive, pro-business environment”.

Recruitment for some of the roles has already begun.

Your Voice
Readers Comments
6
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.